Business & Regulation

In a price-challenged environment, successful companies embrace change and new strategies.

What can we learn about outsourcing trends from the last 40 years?

The ABPI releases a manifesto for the UK’s upcoming election.

Will a pilot project to prequalify “generic” biologics improve safe access to medicines?

With big regulatory changes on the horizon, RAPS invests in Europe.

PhRMA weeds out 22 members after revising membership rules.

Charlotte Barker speaks with Lukas Utiger from Patheon.

We Sit Down With Daniel O'Connor, Medical Assessor at the MHRA, UK.

President Trump has the opportunity to get healthcare moving by boosting biogeneric use.

Hygiene is essential to pharma, but there are a suprising number of ways it can go wrong.